Claus-Christian Glüer

Claus-Christian Glüer

Auto-generated profile, based on publicly available information

Claus-Christian Glüer

University of Kiel, Kiel, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
CGClaus C Dr Glüer
Claus C Dr Glüer
RERichard Eastell
Richard Eastell
DRDavid M Reid
David M Reid
DFDieter Felsenberg
Dieter Felsenberg
CRChristian Roux
Christian Roux
SKSami Kolta
Sami Kolta
We compared the performance of five QUS devices with DXA in a population-based sample of 2837 women. All QUS approaches discriminated women with and without osteoporotic vertebral fractures. QUS of the calcaneus performed as well as central DXA. Introduction: Quantitative ultrasound (QUS) methods have found widespread use for the assessment of bone status in osteoporosis, but their optimal use remains to be established. To determine QUS performance for current devices in direct comparison with central DXA, we initiated a large population-based investigation, the Osteoporosis and Ultrasound Study (OPUS). Materials and Methods: A total of 463 women 20–39 years of age and 2374 women 55–79 years of age were measured on five different QUS devices along with DXA of the spine and the proximal femur. Their vertebral fracture status was evaluated radiographically. The association of QUS and DXA with vertebral fracture status was evaluated using logistic regression. Results: All QUS approaches tested discriminated women with and without osteoporotic vertebral fractures (20% height reduction), with age-adjusted standardized odds ratios ranging 1.2–1.3 for amplitude-dependent speed of sound (AD-SOS) at the finger phalanges, 1.2–1.4 for broadband ultrasound attenuation (BUA) at the calcaneus, and 1.4–1.5 for speed of sound (SOS) at the calcaneus, 1.4–1.6 for DXA of the total femur, and 1.5–1.6 for DXA at the spine. For more severe fractures (40% height reduction), age-adjusted standardized odds ratios increased to up to 1.9 for DXA of the spine and 2.3 for SOS of the calcaneus. Conclusions: In conclusion, all five QUS devices tested showed significant age-adjusted differences between subjects with and without vertebral fracture. When selecting the strongest variable, QUS of the calcaneus worked as well as central DXA for identification of women at high risk for prevalent osteoporotic vertebral fractures. QUS-based case-finding strategies would allow halving the number of radiographs in high-risk populations, and this strategy works increasingly well for women with more severe vertebral fractures. It is likely that the good performance of QUS was in part achieved by rigorous quality assurance measures that should also be used in clinical practice.

11 August 2023 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JKJ.A. Kanis
J.A. Kanis
HJH. Johansson
H. Johansson
EME.V. McCloskey
E.V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
WLW.D. Leslie
W.D. Leslie

31 May 2022 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVL. Vandenput
L. Vandenput
HJH. Johansson
H. Johansson
EME. V. McCloskey
E. V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
JKJ. A. Kanis
J. A. Kanis

1 December 2015 in Bone
Verified
Journal Article
Closed access
CGChristian Graeff
Christian Graeff
GCGraeme M. Campbell
Graeme M. Campbell
JPJaime Peña
Jaime Peña
JBJan Borggrefe
Jan Borggrefe
DPDesmond Padhi
Desmond Padhi
CGClaus-Christian Glüer
Claus-Christian Glüer

17 January 2024 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVLiesbeth Vandenput
Liesbeth Vandenput
HJHelena Johansson
Helena Johansson
EMEugene V. McCloskey
Eugene V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
Marian SchiniMarian Schini
Marian Schini
JKJohn A. Kanis
John A. Kanis

1 June 2019 in Bone Reports
Verified
Journal Article
Open access
AEA. Eisenhauer
A. Eisenhauer
MMM. Müller
M. Müller
AHAlexander Heuser
Alexander Heuser
AKA. Kolevica
A. Kolevica
CGC.-C. Glüer
C.-C. Glüer
JSJ. Schrezenmeir
J. Schrezenmeir
We assessed the potential of Calcium (Ca) isotope fractionation measurements in blood (δ44/42CaBlood) and urine (δ44/42CaUrine) as a new biomarker for the diagnosis of osteoporosis. One hundred post-menopausal women aged 50 to 75 years underwent dual-energy X-ray absorptiometry (DXA), the gold standard for determination of bone mineral density. After exclusion of women with kidney failure and vitamin D deficiency (<25 nmol/l) 80 women remained in the study. Of these women 14 fulfilled the standard diagnostic criteria for osteoporosis based on DXA. Both the δ44/42CaBlood (p < 0.001) and δ44/42CaUrine (p = 0.004) values were significantly different in women with osteoporosis (δ44/42CaBlood: -0.99 ± 0.10‰, δ 44/42CaUrine: +0.10 ± 0.21‰, (Mean ± one standard deviation (SD), n = 14)) from those without osteoporosis (δ44/42CaBlood: -0.84 ± 0.14‰, δ44/42CaUrine: +0.35 ± 0.33‰, (SD), n = 66). This corresponded to the average Ca concentrations in morning spot urine samples ([Ca]Urine) which were higher (p = 0.041) in those women suffering from osteoporosis ([Ca]Urine-Osteoporosis: 2.58 ± 1.26 mmol/l, (SD), n = 14) than in the control group ([Ca]Urine-Control: 1.96 ± 1.39 mmol/l, (SD), n = 66). However, blood Ca concentrations ([Ca]Blood) were statistically indistinguishable between groups ([Ca]Blood, control: 2.39 ± 0.10 mmol/l (SD), n = 66); osteoporosis group: 2.43 ± 0.10 mmol/l (SD, n = 14) and were also not correlated to their corresponding Ca isotope compositions. The δ44/42CaBlood and δ44/42CaUrine values correlated significantly (p = 0.004 to p = 0.031) with their corresponding DXA data indicating that both Ca isotope ratios are biomarkers for osteoporosis. Furthermore, Ca isotope ratios were significantly correlated to other clinical parameters ([Ca]Urine, ([Ca]Urine/Creatinine)) and biomarkers (CRP, CTX/P1NP) associated with bone mineralization and demineralization. From regression analysis it can be shown that the δ44/42CaBlood values are the best biomarker for osteoporosis and that no other clinical parameters need to be taken into account in order to improve diagnosis. Cut-off values for discrimination of subjects suffering from osteoporosis were - 0.85‰ and 0.16‰ for δ44/42CaBlood and δ44/42CaUrine, respectively. Corresponding sensitivities were 100% for δ44/42CaBlood and ~79% for δ44/42CaUrine. Apparent specificities were ~55% for δ44/42CaBlood and ~71%. The apparent discrepancy in the number of diagnosed cases is reconciled by the different methodological approaches to diagnose osteoporosis. DXA reflects the bone mass density (BMD) of selected bones only (femur and spine) whereas the Ca isotope biomarker reflects bone Ca loss of the whole skeleton. In addition, the close correlation between Ca isotopes and biomarkers of bone demineralization suggest that early changes in bone demineralization are detected by Ca isotope values, long before radiological changes in BMD can manifest on DXA. Further studies are required to independently confirm that Ca isotope measurement provide a sensitive, non-invasive and radiation-free method for the diagnosis of osteoporosis.